Replies to post #169567 on Anavex Life Sciences Corp (AVXL)

[jtsmgoblue]

No disrespect to Noble but I can’t begin to imagine how those numbers pencil. I’ve done a lot of business case analysis in my day and it’s not clear how they came up with that type valuation. Either a helluva of a discount rate, unrealistic risk factor, very low PE factor, low drug cost, low margin, etc.

Any insight appreciated.

[Turner2017]

I think Rett approval will put us over $10 easy.